Sign In

Nicholas Goldner, PhD

Founder and CMO @ resistanceBio | Solving Cancer Resistance

Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, a company developing novel therapies targeting cancer treatment resistance mechanisms.1 He is not the CMO as stated in the query, but rather the CEO. Goldner is an entrepreneur and molecular biologist focused on defeating cancer, driven by a personal connection.2

Goldner's professional experience includes:

  1. CEO and co-founder of resistanceBio (March 2021 - Present)1
  2. Venture Partner at Pioneer Fund (October 2020 - Present)1
  3. Former CEO and co-founder of Viosera Therapeutics (July 2016 - January 2022)1

His educational background comprises:

  • PhD in Molecular Cell Biology from Washington University in St. Louis1
  • BS in Biochemistry from Wisconsin Lutheran College1
  • Participation in Y Combinator1

At resistanceBio, Goldner has developed the ResCu system, a proprietary cancer culture system that predicts resistance mechanisms to therapies.2 His work aims to map the cancer resistome and develop smarter cancer therapies and diagnostics.2

Highlights

May 4 · pmwcintl.com
Nick Goldner - 2023sv - PMWC Precision Medicine World Conference

Related Questions

What inspired Nicholas Goldner to start resistanceBio?
How does the ResCu system work at resistanceBio?
What is the ResistanceRank algorithm used by resistanceBio?
What was Nicholas Goldner's role at Viosera Therapeutics?
How did Nicholas Goldner's experience at Y Combinator influence his career?
Nicholas Goldner, PhD
Nicholas Goldner, PhD, photo 1
Nicholas Goldner, PhD, photo 2
Add to my network

Location

San Francisco Bay Area